35th generic tender (1st)

Summary

The tender concerns the supply of medicines and the conclusion of active-substance-specific rebate agreements with pharmaceutical companies. The procedure is divided into active-substance-specific lots, and each lot relates to a finished medicinal product. The bidder must be a pharmaceutical company or a consortium of pharmaceutical companies, submit the required register extract and other evidence, and note that e-invoicing is required. Price is the only award criterion.